BCI Pharma is an innovative bio-pharmaceutical company focused on small molecule drug discovery. We design innovative chemical libraries and our HTS platform can support your owned library synthesis. We have the expertise to optimize your Hit to clinical candidates and offer consultancy service based on your needs.
Bridge2Health connects you to state-of-the-art healthcare solutions, from bench to bedside. We provide a unique and integrated access to academic research excellence and to personalized medicine tools developed at the University of Liège (ULg) and the University Hospital of Liège (CHU) in Belgium.
Bristol-Myers Squibb is a differentiated company, led by our unique BioPharma strategy that leverages the reach and resources of a major pharma company paired with the entrepreneurial spirit and agility of a biotech firm. We work every day to deliver innovative medicines for patients with serious and life-threatening diseases.